Physician profile
Alexis P Chidi
NPI 1265973481
$5,948.69
in general payments reported to CMS, 2019-2025
11 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,581 · 2024: $4,115 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,533 · Grant: $1,235 · Food and Beverage: $1,181 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,532.73 |
| Grant | $1,235.41 |
| Food and Beverage | $1,180.55 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,284.11 | 2024 | |
| Medical Device Business Services, INC. | $1,338.97 | 2024 | Echelon Flex |
| Medtronic, INC. | $1,235.41 | 2023 | |
| Ethicon US, LLC | $180.11 | 2024 | Surgicel Nu-Knit, Echelon Endopath, Echelon; Endopath |
| Astrazeneca Pharmaceuticals LP | $168.44 | 2024-2025 | Tagrisso |
| Atricure, INC. | $167.59 | 2024 | |
| Abiomed | $152.04 | 2023 | Impella |
| Stryker Corporation | $146.51 | 2025 | 1788 |
| Silk Road Medical, INC. | $101.24 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Arthrex, INC. | $92.59 | 2023 | |
| Kerecis Limited | $81.68 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Chidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.